Literature DB >> 21352225

Translating medical evidence to promote informed health care decisions.

Lauren McCormack1, Katherine Treiman, Carla Bann, Pamela Williams-Piehota, David Driscoll, Jon Poehlman, Cindy Soloe, Kathleen Lohr, Stacey Sheridan, Carol Golin, Samuel Cykert, Russell Harris.   

Abstract

OBJECTIVE: To examine the effects of a community-based intervention on decisions about prostate-specific antigen (PSA) screening using multiple measures of informed decision making (IDM). DATA SOURCES/STUDY
SETTING: Nonequivalent control group time series design collecting primary data in late 2004 and 2005. STUDY
DESIGN: We developed a multimodal intervention designed to convey the medical uncertainty about the benefits of PSA screening and early treatment and the limited predictive ability of both the PSA test and pathological specimens collected from prostate biopsy. We examined (1) patients' recognition that there is a decision to be made about PSA screening, (2) prostate cancer knowledge levels, (3) their preferred and actual levels of participation in decision making about screening at three points in time, and (4) screening decision. DATA COLLECTION: Baseline data collection occurred in community-based organizations. These organizations served as recruiting sources and as sites for the intervention. We collected follow-up data by mail with telephone reminders. PRINCIPAL
FINDINGS: Our intervention was associated with greater recognition of the PSA test as a decision to be made, levels of knowledge, both preferred and actual levels of involvement in decision making, but did not have an impact on the screening decision.
CONCLUSIONS: Community-based interventions can influence key measures of IDM about PSA screening. © Health Research and Educational Trust.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352225      PMCID: PMC3165184          DOI: 10.1111/j.1475-6773.2011.01248.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  34 in total

1.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

2.  Screening for prostate cancer: recommendation and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

3.  Risk communication in practice: the contribution of decision aids.

Authors:  Annette M O'Connor; France Légaré; Dawn Stacey
Journal:  BMJ       Date:  2003-09-27

4.  Comments and response on the USPSTF recommendation on screening for breast cancer.

Authors:  Nananda F Col; Moritz H Hansen; Baruch Fischhoff; Steven G Pauker
Journal:  Ann Intern Med       Date:  2010-02-15       Impact factor: 25.391

5.  Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA).

Authors: 
Journal:  Oncology (Williston Park)       Date:  2000-02       Impact factor: 2.990

Review 6.  Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.

Authors:  Russell Harris; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

7.  The accuracy of primary care patients' self-reports of prostate-specific antigen testing.

Authors:  Robert J Volk; Alvah R Cass
Journal:  Am J Prev Med       Date:  2002-01       Impact factor: 5.043

8.  Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites.

Authors:  Evelyn C Y Chan; Sally W Vernon; Chul Ahn; Anthony Greisinger
Journal:  Am J Public Health       Date:  2004-08       Impact factor: 9.308

9.  Enthusiasm for cancer screening in the United States.

Authors:  Lisa M Schwartz; Steven Woloshin; Floyd J Fowler; H Gilbert Welch
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

10.  Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

Authors:  Brenda E Sirovich; Lisa M Schwartz; Steven Woloshin
Journal:  JAMA       Date:  2003-03-19       Impact factor: 56.272

View more
  5 in total

1.  Parent Preferences for Shared Decision-making in Acute Versus Chronic Illness.

Authors:  Dina M Tom; Christian Aquino; Anthony R Arredondo; Byron A Foster
Journal:  Hosp Pediatr       Date:  2017-10

2.  Establishing the infrastructure to conduct comparative effectiveness research toward the elimination of disparities: a community-based participatory research framework.

Authors:  Danyell S Wilson; Virna Dapic; Dawood H Sultan; Euna M August; B Lee Green; Richard Roetzheim; Brian Rivers
Journal:  Health Promot Pract       Date:  2013-02-21

3.  Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.

Authors:  Alice G Ames; Alice Jaques; Obioha C Ukoumunne; Alison D Archibald; Rony E Duncan; Jon Emery; Sylvia A Metcalfe
Journal:  Health Expect       Date:  2012-10-15       Impact factor: 3.377

4.  Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.

Authors:  Stacey L Sheridan; Carol Golin; Audrina Bunton; John B Lykes; Bob Schwartz; Lauren McCormack; David Driscoll; Shrikant I Bangdiwala; Russell P Harris
Journal:  BMC Med Inform Decis Mak       Date:  2012-11-13       Impact factor: 2.796

Review 5.  Interventions for increasing the use of shared decision making by healthcare professionals.

Authors:  France Légaré; Rhéda Adekpedjou; Dawn Stacey; Stéphane Turcotte; Jennifer Kryworuchko; Ian D Graham; Anne Lyddiatt; Mary C Politi; Richard Thomson; Glyn Elwyn; Norbert Donner-Banzhoff
Journal:  Cochrane Database Syst Rev       Date:  2018-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.